Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
Patent
1977-07-13
1979-02-27
Curtis, Allen B.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant or stably-transformed bacterium encoding one or...
260564RF, 260239A, 2603265J, 424244, 424267, 424274, 546204, 546190, A61K 31155, C07C12300
Patent
active
041419928
ABSTRACT:
2,6 Anthraquinonylene cycloalkylcarboxamidines and halobenzamidines that are effective against cecal and hepatic amebic infestations in warm-blooded animals, methods of treatment therewith and therapeutic compositions thereof.
REFERENCES:
patent: 3184482 (1965-05-01), Steiger
patent: 3654319 (1972-04-01), Neeff
patent: 3960947 (1976-06-01), Duerr et al.
patent: 3972932 (1976-08-01), Panneman
patent: 4078086 (1978-03-01), Winkelmann et al.
Fabio Paul F.
Fields Thomas L.
Lang, Jr. Stanley A.
Lin Yang-I
Murdock Keith C.
American Cyanamid Company
Caroli Claude J.
Curtis Allen B.
LandOfFree
Cycloalkylcarboxyamidines and halobenzamidines as anti-amebic ag does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cycloalkylcarboxyamidines and halobenzamidines as anti-amebic ag, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cycloalkylcarboxyamidines and halobenzamidines as anti-amebic ag will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-723102